Geode Capital Management’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $110M | Sell |
2,993,866
-1,148,548
| -28% | -$42.3M | 0.01% | 969 |
|
|
2025
Q1 | $147M | Buy |
4,142,414
+56,215
| +1% | +$1.99M | 0.01% | 763 |
|
|
2024
Q4 | $180M | Buy |
4,086,199
+459,174
| +13% | +$20.2M | 0.01% | 672 |
|
|
2024
Q3 | $165M | Buy |
3,627,025
+291,369
| +9% | +$13.2M | 0.01% | 700 |
|
|
2024
Q2 | $129M | Buy |
3,335,656
+282,965
| +9% | +$11M | 0.01% | 770 |
|
|
2024
Q1 | $98.4M | Buy |
3,052,691
+73,907
| +2% | +$2.38M | 0.01% | 929 |
|
|
2023
Q4 | $85.4M | Buy |
2,978,784
+906,052
| +44% | +$26M | 0.01% | 960 |
|
|
2023
Q3 | $57.4M | Buy |
2,072,732
+124,272
| +6% | +$3.44M | 0.01% | 1141 |
|
|
2023
Q2 | $52.1M | Buy |
1,948,460
+214,383
| +12% | +$5.73M | 0.01% | 1210 |
|
|
2023
Q1 | $37.6M | Buy |
1,734,077
+287,221
| +20% | +$6.22M | ﹤0.01% | 1383 |
|
|
2022
Q4 | $34.5M | Buy |
1,446,856
+68,304
| +5% | +$1.63M | ﹤0.01% | 1401 |
|
|
2022
Q3 | $27.2M | Buy |
1,378,552
+212,794
| +18% | +$4.2M | ﹤0.01% | 1524 |
|
|
2022
Q2 | $22.7M | Buy |
1,165,758
+44,817
| +4% | +$873K | ﹤0.01% | 1673 |
|
|
2022
Q1 | $28.6M | Buy |
1,120,941
+17,444
| +2% | +$445K | ﹤0.01% | 1647 |
|
|
2021
Q4 | $27.8M | Buy |
1,103,497
+22,558
| +2% | +$568K | ﹤0.01% | 1735 |
|
|
2021
Q3 | $29.7M | Buy |
1,080,939
+136,881
| +14% | +$3.77M | ﹤0.01% | 1701 |
|
|
2021
Q2 | $30M | Buy |
944,058
+165,458
| +21% | +$5.25M | ﹤0.01% | 1695 |
|
|
2021
Q1 | $35.7M | Buy |
778,600
+136,235
| +21% | +$6.25M | 0.01% | 1484 |
|
|
2020
Q4 | $25.4M | Buy |
642,365
+16,265
| +3% | +$644K | ﹤0.01% | 1571 |
|
|
2020
Q3 | $21.8M | Buy |
626,100
+370,940
| +145% | +$12.9M | ﹤0.01% | 1481 |
|
|
2020
Q2 | $8.06M | Buy |
255,160
+134,282
| +111% | +$4.24M | ﹤0.01% | 2062 |
|
|
2020
Q1 | $2.65M | Buy |
+120,878
| New | +$2.65M | ﹤0.01% | 2519 |
|